Analysis of correlated domain motions in IgG light chain reveals possible mechanisms of immunological signal transduction

Proteins: Structure, Function and Genetics

Volumn 59, Issue 3, 2005, Pages 545-554

  Król, Marcin ^a,b   Roterman, Irena ^a   Piekarska, Barbara ^a   Konieczny, Leszek ^a   Rybarska, Janina ^a   Stopa, Barbara ^a   Spólnik, Paweł ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

Congo red; Dynamic cross correlation matrix; IgG light chain; Immunological signal; Molecular dynamics simulation

Indexed keywords

CONGO RED; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEMENT FIXATION; MICELLE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SIMULATION;

COMPUTER SIMULATION; DATABASES, PROTEIN; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAINS; LIGANDS; MODELS, MOLECULAR; PEPTIDES; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

EID: 17844408143     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.20434     Document Type: Article

References (71)

1. Kehoe J. The structural basis for the biological properties of immunoglobulins. In: Litman GW, editor. Immunoglobulins. New York: Plenum Medical Books Co.; 1978.
2. Cohn M. The take-home lesson-1971. Ann NY Acad Sci 1971;190:529-584.
3. Metzger H. Effect of antigen binding on the properties of antibody. Adv Immunol 1974;18:169-207.
4. Metzger H. The effect of antigen on antibodies: recent studies. Contemp Top Mol Immunol 1978;7:119-152.
5. Metzger H. Antibodies as effector molecules. Harvey Lect Ser 1986;80:49-66.
6. Burton DR. Immunoglobulin G: functional sites. Mol Immunol 1985;22:161-206.
7. Sheriff S, Silverton EW, Padlan EA, Cohen GH, Smith-Gill SJ, Finzel BC, Davies DR. Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci USA 1987;84:8075-8079.
8. Fischmann T, Souchon H, Riottot MM, Tello D, Poljak RJ. Crystallization and preliminary X-ray diffraction studies of two new antigen-antibody (lysozyme-Fab) complexes. J Mol Biol 1988;203:527-529.
9. Schopes B. A genetically engineered human IgG with limited flexibility fully initiates cytolysis via complement. Mol Immunol 1993;30:603-609.
10. Monaco-Malbet S, Berthet-Colominas C, Novelli A, Battai N, Piga N, Cheynet V, Mallet F, Cusack S. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Structure Fold Des 2000;8:1069-1077.
11. Rini JM, Schulze-Gahmen U, Wilson IA. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 1992;255:959-965.
12. Chan LA, Phillips ML, Wims LA, Trinh KR, Denham J, Morrison SL. Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions. Mol Immunol 2004;41:527-538.
13. Oda M, Kozono H, Morii H, Azuma T. Evidence of allosteric conformational changes in the antibody constant region upon antigen binding. Int Immunol 2003;15:417-426.
14. Nakamura K, Tanaka Y, Fujino I, Hirayama N, Shitara K, Hanai N. Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody. Mol Immunol 2000;37:1035-1046.
15. van den Elsen J, Vandeputte-Rutten L, Kroon J, Gros P. Bactericidal antibody recognition of meningococcal PorA by induced fit. Comparison of liganded and unliganded Fab structures. J Biol Chem 1999;274:1495-1501.
16. Guddat LW, Shan L, Fan ZC, Andersen KN, Rosauer R, Linthicum DS, Edmundson AB. Intramolecular signaling upon complexation. FASEB J 1995;9:101-106.
17. Guddat LW, Shan L, Anchin JM, Linthicum DS, Edmundson AB. Local and transmitted conformational changes on complexation of an anti-sweetener Fab. J Mol Biol 1994;236:247-274.
18. Roterman I, No KT, Piekarska B, Kaszuba J, Pawlicki R, Rybarska J, Konieczny L. Bis azo dyes-studies on the mechanism of complex formation with IgG modulated by heating or antigen binding. J Physiol Pharmacol 1993;44:213-232.
19. Rybarska J, Konieczny L, Roterman I, Piekarska B. The effect of azo dyes on the formation of immune complexes. Arch Immunol Ther Exp (Warsz) 1991;39:317-327.
20. Stopa B, Gorny M, Konieczny L, Piekarska B, Rybarska J, Skowronek M, Roterman I. Supramolecular ligands: Monomer structure and protein ligation capability. Biochimie 1998;80:963-968.
21. Kaszuba J, Konieczny L, Piekarska B, Roterman I, Rybarska J. Bis-azo dyes interference with effector activation of antibodies. J Physiol Pharmacol 1993;44:233-242.
22. Piekarska B, Rybarska J, Stopa B, Zemanek G, Krol M, Roterman I, Konieczny L. Supramolecularity creates nonstandard protein ligands. Acta Biochim Pol 1999;46:841-851.
23. Piekarska B, Konieczny L, Rybarska J, Stopa B, Spolnik P, Roterman I, Krol M. Intramolecular signaling in immunoglobulins-new evidence emerging from the use of supramolecular protein ligands. J Physiol Pharmacol 2004;55:487-501.
24. Piekarska B, Konieczny L, Rybarska J, Stopa B, Zemanek G, Szneler E, Krol M, Nowak M, Roterman I. Heat-induced formation of a specific binding site for self-assembled Congo Red in the V domain of immunoglobulin L chain lambda. Biopolymers 2001;59:446-456.
25. Spolnik P, Piekarska B, Stopa B, Konieczny L, Zemanek G, Rybarska J, Krol M, Nowak M, Roterman I. The structural abnormality of myeloma immunoglobulins tested by Congo red binding. Med Sci Monit 2003;9:BR145-153.
26. Jung S, Spinelli S, Schimmele B, Honegger A, Pugliese L, Cambillau C, Pluckthun A. The importance of framework residues H6, H7 and H10 in antibody heavy chains: Experimental evidence for a new structural subclassification of antibody V(H) domains. J Mol Biol 2001;309:701-716.
27. Ohage E, Steipe B. Intrabody construction and expression. I. The critical role of VL domain stability. J Mol Biol 1999;291:1119-1128.
28. Krol M, Roterman I, Piekarska B, Konieczny L, Rybarska J, Stopa B. Local and long-range structural effects caused by the removal of the N-terminal polypeptide fragment from immunoglobulin L chain lambda. Biopolymers 2003;69:189-200.
29. Stopa B, Piekarska B, Konieczny L, Rybarska J, Spolnik P, Zemanek G, Roterman I, Krol M. The structure and protein binding of amyloid-specific dye reagents. Acta Biochim Pol 2003;50:1213-1227.
30. Rybarska J, Piekarska B, Stopa B, Zemanek G, Konieczny L, Nowak M, Krol M, Roterman I, Szymczakiewicz-Multanowska A. Evidence that supramolecular Congo red is the sole ligation form of this dye for L chain lambda derived amyloid proteins. Folia Histochem Cytobiol 2001;39:307-314.
31. Sotriffer CA, Liedl KR, Linthicum DS, Rode BM, Varga JM. Ligand-induced domain movement in an antibody Fab: molecular dynamics studies confirm the unique domain movement observed experimentally for Fab NC6.8 upon complexation and reveal its segmental flexibility. J Mol Biol 1998;278:301-306.
32. Lim K, Herron JN. Molecular dynamics of the anti-fluorescein 4-4-20 antigen-binding fragment. 1. Computer simulations. Biochemistry 1995;34:6962-6974.
33. Berman HM, Bhat TN, Bourne PE, Feng Z, Gilliland G, Weissig H, Westbrook J. The Protein Data Bank and the challenge of structural genomics. Nat Struct Biol 2000;7 Suppl:957-959.
34. Huang DB, Ainsworth CF, Stevens FJ, Schiffer M. Three quaternary structures for a single protein. Proc Natl Acad Sci USA 1996;93:7017-7021.
35. InsightII User Guide. San Diego: Biosym/MSI; October 1995.
36. Roterman I, Rybarska J, Konieczny L, Skowronek M, Stopa B, Piekarska B, Bakalarski G. Congo red bound to α-proteinase inhibitor as a model of supramolecular ligand and protein complex. Comp Chem 1998;22:61-70.
37. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E. Equation of state caclulations by fast computing machines. J Chem Phys 1953;21:1087-1092.
38. Dinner AR. Monte Carlo simulations of protein folding. PhD Thesis, Harvard University, Cambridge, MA. 1999.
39. Apostolakis J, Plückthun A, Caflisch A. Docking small ligands in flexible binding sites. J Comp Chem 1998;19:21-37.
40. Mezei M. Optimal position of solute for simulations. J Comp Chem 1997;18:812-815.
41. Skowronek M, Stopa B, Konieczny L, Rybarska J, Piekarska B, Szneler E, Bakalarski G, Roterman I. Self-assembly of Congo red-a theoretical and experimental approach to identify its supramolecular organization in water and salt solutions. Biopolymers 1998;46:267-281.
42. Brooks B, Bruccoleri R, Olafson B, States D, Swaminathan S, Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comp Chem 1983;4:187-217.
43. MacKerell ADJ, Bashford D, Bellot M, Dunbrack RLJ, Evenseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, and others. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 1998;102:3586-3616.
44. Krol M, Borowski T, Roterman I, Piekarska B, Stopa B, Rybarska J, Konieczny L. Force-field parametrization and molecular dynamics simulations of Congo red. J Comput Aided Mol Des 2004;18:41-53.
45. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926-935.
46. Ryckaert J, Ciccotti G, Berendsen HJ. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-Alkenes. J Comp Phys 1977;23:327-341.
47. Essman U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys 1995;103:8577-8593.
48. Krol M. Analysis of the effect of electrostatic energy truncation in molecular dynamics simulations of immunoglobulin G light chain dimer. J Mol Model (Online) 2003;9:316-324.
49. Feller SE, Zhang Y, Pastor RW, Brooks BR. Constant pressure molecular dynamics simulation: the Langevin piston method. J Chem Phys 1995;103:4613-4621.
50. Ichiye T, Karplus M. Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins 1991;11:205-217.
51. Swaminathan S, Harte WHJ, Beveridge DL. Investigation of domain structure in proteins via molecular dynamics simulation: application to HIV-1 protease dimer. J Am Chem Soc 1991;113:2717-2721.
52. Sotriffer CA, Rode BM, Varga JM, Liedl KR. Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: 11Large effects of a small hapten. Biophys J 2000;79:614-628.
53. Arnold GE, Ornstein RL. Molecular dynamics study of time-correlated protein domain motions and molecular flexibility: cytochrome P450BM-3. Biophys J 1997;73:1147-1159.
54. Hunenberger PH, Mark AE, van Gunsteren WF. Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations. J Mol Biol 1995;252:492-503.
55. Wall J, Murphy CL, Solomon A. In vitro immunoglobulin light chain fibrillogenesis. Methods Enzymol 1999;309:204-217.
56. Ishikawa N, Chiba T, Chen LT, Shimizu A, Ikeguchi M, Sugai S. Remarkable destabilization of recombinant alpha-lactalbumin by an extraneous N-terminal methionyl residue. Protein Eng 1998;11:333-335.
57. Ewert S, Huber T, Honegger A, Pluckthun A. Biophysical properties of human antibody variable domains. J Mol Biol 2003;325:531-553.
58. Redfield C, Smith RA, Dobson CM. Structural characterization of a highly-ordered "molten globule" at low pH. Nat Struct Biol 1994;1:23-29.
59. Yokoyama H, Mizutani R, Satow Y, Komatsu Y, Ohtsuka E, Nikaido O. Crystal structure of the 64M-2 antibody Fab fragment in complex with a DNA dT(6-4)T photoproduct formed by ultraviolet radiation. J Mol Biol 2000;299:711-723.
60. Wilson IA, Stanfield RL. Antibody-antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol 1994;4:857-867.
61. Stanfield RL, Wilson IA. Antigen-induced conformational changes in antibodies: a problem for structural prediction and design. Trends Biotechnol 1994;12:275-279.
62. Colman PM, Laver WG, Varghese JN, Baker AT, Tulloch PA, Air GM, Webster RG. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 1987;326:358-363.
63. Piekarska B, Skowronek M, Rybarska J, Stopa B, Roterman I, Konieczny L. Congo red-stabilized intermediates in the lambda light chain transition from native to molten state. Biochimie 1996;78:183-189.
64. Roterman I, Konieczny L, Stopa B, Rybarska J, Piekarska B. Heat-induced structural changes in the Fab fragment of IgG recognized by molecular dynamics stimulation-implications for signal transduction in antibodies. Folia Biol (Krakow) 1994;42:115-128.
65. Campbell DG, Williams AF, Bayley PM, Reid KB. Structural similarities between Thy-1 antigen from rat brain and immunoglobulin. Nature 1979;282:341-342.
66. Halaby DM, Mornon JP. The immunoglobulin superfamily: an insight on its tissular, species, and functional diversity. J Mol Evol 1998;46:389-400.
67. Saul FA, Amzel LM, Poljak RJ. Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin new at 2.0 Å resolution. J Biol Chem 1978;253:585-597.
68. Nagar B, Overduin M, Ikura M, Rini JM. Structural basis of calcium-induced E-cadherin rigidification and dimerization. Nature 1996;380:360-364.
69. Jones EY, Harlos K, Bottomley MJ, Robinson RC, Driscoll PC, Edwards RM, Clements JM, Dudgeon TJ, Stuart DI. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution. Nature 1995;373:539-544.
70. Casasnovas JM, Springer TA, Liu JH, Harrison SC, Wang JH. Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 1997;387:312-315.
71. Barclay TA. Membrane proteins with immunoglobulin-like domains-a master superfamily of interaction molecules. Semin Immunol 2003;15:215-223.